Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

drug lifecycle

- PMLiVE

ViiV and Janssen plan pivotal trials of monthly HIV treatment

Rilpivirine – cabotegravir combination could provide a monthly option

- PMLiVE

Michael J Fox Foundation backs wearable device trial

Partners with chip manufacturer Intel and Cynapsus Therapeutics on Parkinson's study

- PMLiVE

Up in smoke

The side-lining of efficacy in medical cannabis debates

12 Connected Health

Seizing the opportunities in a new era of care

Havas Lynx

- PMLiVE

Less is more: how risk-based monitoring is changing trials

A quality risk management approach is one of the biggest drivers for change in clinical research

- PMLiVE

Getting patients to engage with clinical trials

The EUPATI European initiative and increasing public knowledge of research

- PMLiVE

Harnessing clinical data

A greater focus on stakeholders could improve pharma's trial challenges

Infographic: North Asia

An overview of the five most-commonly researched, largest pharma markets in North Asia.

Research Partnership

- PMLiVE

Get Real! The Rise of Observational Data In Healthcare

Real world data is now becoming a serious research tool for pharma, but just what can it add to the golden standard that is the randomised clinical trial?

- PMLiVE

WHO calls for publication of previously unreported studies

Organisation claims results from clinical trials should be reported within 12 months

- PMLiVE

Baxter haemophilia drug clears phase III trial

BAX 817 shown to resolve more than 90% of acute bleeds

Eli Lilly HQ

Lilly sets back evacetrapib data deadline

Cholesterol drug trials extended by six months

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links